AU2015237243A1 - Progesterone formulations - Google Patents

Progesterone formulations Download PDF

Info

Publication number
AU2015237243A1
AU2015237243A1 AU2015237243A AU2015237243A AU2015237243A1 AU 2015237243 A1 AU2015237243 A1 AU 2015237243A1 AU 2015237243 A AU2015237243 A AU 2015237243A AU 2015237243 A AU2015237243 A AU 2015237243A AU 2015237243 A1 AU2015237243 A1 AU 2015237243A1
Authority
AU
Australia
Prior art keywords
progesterone
pharmaceutical composition
solubilized
capsule
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015237243A
Other languages
English (en)
Inventor
Julia Amadio
Brian Bernick
Janice Cacace
Peter Persicaner
Frederick Sancilio
Thorsteinn Thorsteinsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TherapeuticsMD Inc
Original Assignee
TherapeuticsMD Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TherapeuticsMD Inc filed Critical TherapeuticsMD Inc
Publication of AU2015237243A1 publication Critical patent/AU2015237243A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU2015237243A 2014-03-28 2015-03-27 Progesterone formulations Abandoned AU2015237243A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461972068P 2014-03-28 2014-03-28
US61/972,068 2014-03-28
PCT/US2015/023041 WO2015148952A1 (en) 2014-03-28 2015-03-27 Progesterone formulations

Publications (1)

Publication Number Publication Date
AU2015237243A1 true AU2015237243A1 (en) 2016-09-29

Family

ID=54196452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015237243A Abandoned AU2015237243A1 (en) 2014-03-28 2015-03-27 Progesterone formulations

Country Status (10)

Country Link
EP (1) EP3122364A4 (ko)
JP (2) JP2017509630A (ko)
KR (1) KR20160137597A (ko)
AR (1) AR099872A1 (ko)
AU (1) AU2015237243A1 (ko)
CA (1) CA2942568A1 (ko)
IL (1) IL247828A0 (ko)
MX (1) MX2016011706A (ko)
RU (1) RU2016136666A (ko)
WO (1) WO2015148952A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081726A1 (en) * 2018-10-17 2020-04-23 Stadler Sarah Sheehan Methods of treating menopausal symptoms using low dose progesterone
CN112336699A (zh) * 2019-08-09 2021-02-09 南京科宁检测科技有限公司 一种黄体酮阴道缓释软胶囊及其制备方法
US20220105107A1 (en) * 2020-10-01 2022-04-07 Michael Liguori Bioidentical progesterone cream infused with nanoemulsified cbd

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU7709901A (en) * 2000-07-24 2002-02-05 Upjohn Co Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilicdrugs
JP2005526083A (ja) * 2002-03-14 2005-09-02 ワトソン ファーマシューティカルズ， インコーポレイテッド プロゲステロンの経口薬物送達システム
US8663681B2 (en) * 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US20110312927A1 (en) * 2010-06-18 2011-12-22 Satish Kumar Nachaegari Progesterone Containing Oral Dosage Forms and Related Methods
US9301920B2 (en) * 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) * 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) * 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies

Also Published As

Publication number Publication date
AR099872A1 (es) 2016-08-24
IL247828A0 (en) 2016-11-30
RU2016136666A (ru) 2018-05-03
EP3122364A1 (en) 2017-02-01
CA2942568A1 (en) 2015-10-01
RU2016136666A3 (ko) 2018-11-07
MX2016011706A (es) 2017-05-01
WO2015148952A1 (en) 2015-10-01
KR20160137597A (ko) 2016-11-30
JP2017509630A (ja) 2017-04-06
EP3122364A4 (en) 2017-10-25
JP2019206540A (ja) 2019-12-05

Similar Documents

Publication Publication Date Title
AU2018222947B2 (en) Progesterone Formulations
JP7198177B2 (ja) 天然の併用ホルモン補充療法剤及び治療
US11865179B2 (en) Progesterone formulations having a desirable PK profile
US20190381068A1 (en) Progesterone formulations having a desirable pk profile
US8846649B2 (en) Natural combination hormone replacement formulations and therapies
US20140370084A1 (en) Estradiol formulations and therapies
JP2019206540A (ja) プロゲステロン製剤

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application